Novartis AG Common Stock (NVS)
R&D Expenses
$11.28B
TTM · Period ending: · USD
NVS R&D Expenses
Latest reported$11.28Bperiod ending
Latest reported$11.28Bperiod ending
NVS TTM R&D Expenses ($573.00M → $11.28B)
TTM R&D Expenses
High-resolution chart · PNG
NVS r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 560,000,000 | |
| 573,000,000 | |
| 573,000,000 |